Exploiting steroid-cyclodextrin complexes for selective determination of Estradiol Valerate and Norethisterone Acetate by synchronous fluorescence spectrofluorimetry

被引:11
作者
Arafa, Reham M. [1 ]
Yehia, Ali M. [1 ,2 ]
Abbas, Samah S. [1 ]
Amer, Sawsan M. [1 ]
机构
[1] Cairo Univ, Fac Pharm, Analyt Chem Dept, El Kasr El Aini St, Cairo 11562, Egypt
[2] Badr Univ Cairo, Sch Pharm & Pharmaceut Ind, Chem Dept, Cairo 11829, Egypt
关键词
Estradiol valerate; Norethisterone acetate and synchronous fluorescence spectroflourimetry; FTO;
D O I
10.1016/j.saa.2019.117237
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Inclusion complexes of beta-cyclodextrin with Estradiol valerate (EST) or Norethisterone acetate (NOR) have been utilized for synchronous fluorescence spectrofluorimetry. beta-cyclodextrin improves fluorescence intensity as well as water solubility of the studied drugs. Samples in aqueous medium adjusted with ammonia were used in synchronous fluorescence to resolve the overlapped emission spectra. The effects of beta-cyclodextrin concentration and Delta lambda have been optimized for sensitive and selective analysis of EST and NOR binary mixture. Synchronous fluorescence intensity of the two drugs is measured at Delta lambda of 70 nm. EST and NOR can be simultaneously determined at 230 nm and 270 nm, respectively. Calibration curves were linear over the ranges of 0.5-6.0 mu g mL(-1) and 0.2-2.0 mu g mL(-1) for EST and NOR, respectively. Official guidelines were followed to estimate the validation parameters of the proposed method. The detection limits were 0.08 mu g mL(-1) for EST and 0.007 mu g mL(-1) for NOR. The proposed method was successfully used for the analysis of EST and NOR in their commercial preparations and the obtained results revealed statistical agreement with those obtained by application of the reported method for both drugs. The proposed method is compared favorably to previously published method in terms of simplicity and hazardous solvent consumption. (C) 2019 Published by Elsevier B.V.
引用
收藏
页数:7
相关论文
共 13 条
[1]   Changes in normal lipid profit of menopausal women with combined hormone replacement therapy -: Comparative clinical trial of two hormonal combinations (conjugated estrogens medroxyprogesterone acetate versus estradiol valerate cyproterone acetate) [J].
Alwers, R ;
Urdinola, J ;
Onatra, W ;
Sánchez, F ;
Posso, H .
MATURITAS, 1999, 32 (01) :41-50
[2]  
Andrade-Eiroa A, 2010, TRAC-TREND ANAL CHEM, V29, P885, DOI 10.1016/j.trac.2010.04.010
[3]   APPLICATION OF SYNCHRONOUS EXCITATION SPECTROFLUORIMETRY TO DRUG ANALYSIS [J].
ANDRE, JC ;
BAUDOT, P ;
NICLAUSE, M .
CLINICA CHIMICA ACTA, 1977, 76 (01) :55-66
[4]  
[Anonymous], 2007, US PHARMACOPEIA 30 N, V24
[5]   Application of normal fluorescence and stability-indicating derivative synchronous fluorescence spectroscopy for the determination of gliquidone in presence of its fluorescent alkaline degradation product [J].
E-Ghobashy, Mohamed R. ;
Yehia, Ali M. ;
Helmy, Aya H. ;
Youssef, Nadia F. .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2018, 188 :619-625
[6]   Characterization of the interaction of FTO protein with thioglycolic acid capped CdTe quantum dots and its analytical application [J].
Ge, Baoyu ;
Li, Zhigang ;
Yang, Lingling ;
Wang, Ruiyong ;
Chang, Junbiao .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2015, 149 :667-673
[7]  
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Validation of analytical procedures: Text and methodology Q2(R1)
[8]  
James T., 1973, J ASS ANAL CHEM, V7, P56
[9]   HPLC ANALYSIS OF INJECTABLE CONTRACEPTIVE PREPARATION CONTAINING NORETHISTERONE ENANTHATE AND ESTRADIOL VALERATE [J].
JIANG, LX ;
WANG, ZJ ;
MATLIN, SA .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1990, 13 (17) :3473-3479
[10]   Spectrofluorimetric study of estrogen-cyclodextrin inclusion complexes in aqueous systems [J].
Perez, Rocio L. ;
Escandar, Graciela M. .
ANALYST, 2013, 138 (04) :1239-1248